AUG 7, 2026 · INTERVENTIONAL STUDY
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
ClinicalTrials.gov
This is a registry record for a planned feasibility and acceptability study with no results posted; enrollment has not yet begun.
Reported
Planned enrollment26
Primary outcome: Number of partic…9 months
Primary outcome: Percentage of pa…6 weeks